Ind-Swift Laboratories Share Price

• Overview
• News
• Analysis
• Recos
• Financials
• Forecast
• Technicals
• Peers
• Shareholdings
• MF
• F&O
• Corp Actions
• About
• More
  • MF
  • F&O
  • Corp Actions
  • About
• EnglishEnglishहिन्दीગુજરાતીमराठीবাংলাಕನ್ನಡதமிழ்తెలుగు

Ind-Swift Labs News & Analysis

Ind-Swift Labs Share Recommendations

Peer Comparison

Ind-Swift Labs Shareholding Pattern

MF Ownership

Corporate Actions

About Ind-Swift Labs

Ind-Swift Laboratories Ltd., incorporated in the year 1995, is a Small Cap company (having a market cap of Rs 638.73 Crore) operating in Pharmaceuticals sector. Ind-Swift Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals and Sale of services for the year ending 31-Mar-2023.For the quarter ended 31-12-2023, the company has reported a Consolidated Total Income of Rs 294.63 Crore, down .84 % from last quarter Total Income of Rs 297.11 Crore and down 8.23 % from last year same quarter Total Income of Rs 321.04 Crore. Company has reported net profit after tax of Rs 19.53 Crore in latest quarter.The company’s top management includes Mr.Navrattan Munjal, Mr.Himanshu Jain, Mr.Sunil Deshmukh, Mr.Rishav Mehta, Mr.Sahil Munjal, Dr.Ashwani Kumar Vig, Ms.Neerja Chathley, Mr.Rajinder Kumar Gupta, Mr.S P Sharma, Mr.Gagan Aggarwal, Mr.Vijay Singla, Mr.Pardeep Verma. Company has Avishkar Singhal & Associates as its auditors. As on 31-03-2024, the company has a total of 5.91 Crore shares outstanding. Show More

FAQs about Ind-Swift Labs share

• 1. What's the Ind-Swift Labs share price today?
  Ind-Swift Labs share price was Rs 108.10 as on 10 May, 2024, 03:55 PM IST. Ind-Swift Labs share price was up by 2.47% based on previous share price of Rs. 105.5. In last 1 Month, Ind-Swift Labs share price moved down by 14.24%.
• 2. What are the key metrics to analyse Ind-Swift Labs Share Price?
  Key Metrics for Ind-Swift Labs are:

  • PE Ratio of Ind-Swift Labs is 16.44
  • Price/Sales ratio of Ind-Swift Labs is 0.27
  • Price to Book ratio of Ind-Swift Labs is 1.07
• 3. Who are peers to compare Ind-Swift Labs share price?
  Top 10 Peers for Ind-Swift Labs are Albert David Ltd., Medicamen Biotech Ltd., Zim Laboratories Ltd., Kilitch Drugs(I) Ltd., Nectar Lifesciences Ltd., Wanbury Ltd., Panacea Biotec Ltd., Bajaj Healthcare Ltd., Venus Remedies Ltd. and Jagsonpal Pharmaceuticals Ltd.
• 4. Who is the Chief Executive Officer of Ind-Swift Labs?
  Sunil Deshmukh is the Chief Executive Officer of Ind-Swift Labs
• 5. Who are the key owners of Ind-Swift Labs stock?
  Following are the key changes to Ind-Swift Labs shareholding:

  • Promoter holding has not changed in last 9 months and holds 42.0 stake as on 31 Mar 2024
  • Domestic Institutional Investors holding have gone down from 19.49 (30 Jun 2023) to 8.03 (31 Mar 2024)
  • Foreign Institutional Investors holding has gone up from 0.08 (30 Jun 2023) to 0.26 (31 Mar 2024)
  • Other investor holding has gone up from 38.43 (30 Jun 2023) to 49.71 (31 Mar 2024)
• 6. What is the market cap of Ind-Swift Labs?
  Market Capitalization of Ind-Swift Labs stock is Rs 624.25 Cr.
• 7. What is 52 week high/low of Ind-Swift Labs share price?
  52 Week high of Ind-Swift Labs share is Rs 138.45 while 52 week low is Rs 64.85